IFNL3 and fatty liver disease: The IFNL3 genotype, pre-therapy BMI, TC, and C4 were associated with pre-therapy C3 levels, whereas post-therapy BMI, ALT, TC, WBC count, C4, and hepatic steatosis were associated with post-therapy C3 levels.